Charles River Laboratories International, Inc. (CRL)

223.53 -3.24 (-1.43%) USD  |  NYSE  |  Jan 22, 13:55
More

Charles River Laboratories International EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for CRL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Johnson & Johnson Upgrade
UnitedHealth Group, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Moderna, Inc. Upgrade